Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $53.39 USD
Change Today 0.00 / 0.00%
Volume 529.6K
PKI On Other Exchanges
Symbol
Exchange
New York
Berlin
As of 8:04 PM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

perkinelmer inc (PKI) Snapshot

Open
$53.36
Previous Close
$53.39
Day High
$53.55
Day Low
$53.14
52 Week High
05/20/15 - $53.67
52 Week Low
10/15/14 - $38.96
Market Cap
6.0B
Average Volume 10 Days
763.9K
EPS TTM
$1.59
Shares Outstanding
113.2M
EX-Date
07/15/15
P/E TM
33.6x
Dividend
$0.28
Dividend Yield
0.52%
Current Stock Chart for PERKINELMER INC (PKI)

perkinelmer inc (PKI) Related Businessweek News

No Related Businessweek News Found

perkinelmer inc (PKI) Details

PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, research, environmental, industrial, and laboratory services markets worldwide. The company operates through two segments, Human Health and Environmental Health. The Human Health segment develops diagnostics, tools, and applications to help detect diseases earlier, and to accelerate the discovery and development of critical new therapies. It provides early detection for genetic disorders from pregnancy to early childhood, well as flat panel X-ray detectors and infectious disease testing for the diagnostics market; and a suite of solutions, including reagents, liquid handling systems, and detection and imaging technologies that enable scientists to enhance life sciences research and drug discovery processes. This segment’s research portfolio includes instrumentation for automation and detection solutions, and in vitro and in vivo imaging and analysis hardware and software; and a portfolio of consumable products, including drug discovery and research reagents. The Environmental Health segment provides products, services, and solutions to facilitate the creation of safer food and consumer products. It develops and provides analytical technologies, solutions, and services that enable its customers to understand the characterization and health of various aspects, including air, water, soil, and food. This segment also provides analytical instrumentation for the industrial market, which includes the chemical, petrochemical, lubricant, polymer, electronics, pharmaceutical, and food and dietary supplement industries; and laboratory services. The company serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. PerkinElmer, Inc. was founded in 1931 and is headquartered in Waltham, Massachusetts.

7,700 Employees
Last Reported Date: 02/24/15
Founded in 1931

perkinelmer inc (PKI) Top Compensated Officers

Chairman, Chief Executive Officer, President ...
Total Annual Compensation: $1.0M
Chief Financial Officer and Senior Vice Presi...
Total Annual Compensation: $492.3K
Senior Vice President and President of Enviro...
Total Annual Compensation: $400.0K
Senior Vice President and President of Human ...
Total Annual Compensation: $383.1K
Senior Vice President of Administration, Gene...
Total Annual Compensation: $410.4K
Compensation as of Fiscal Year 2014.

perkinelmer inc (PKI) Key Developments

PerkinElmer Inc. Presents at Bank of America Merrill Lynch 2015 Health Care Conference, May-13-2015 10:00 AM

PerkinElmer Inc. Presents at Bank of America Merrill Lynch 2015 Health Care Conference, May-13-2015 10:00 AM. Venue: Encore at the Wynn, 3131 S Las Vegas Blvd, Las Vegas, Nevada, United States. Speakers: Frank A. Wilson, Chief Financial Officer and Senior Vice President.

PerkinElmer Inc. Reports Consolidated Earnings Results for the First Quarter Ended March 29, 2015; Revised Earnings Guidance for Fiscal 2015

PerkinElmer Inc. reported consolidated earnings results for the first quarter ended March 29, 2015. The company reported GAAP earnings per diluted share from continuing operations of $0.36, as compared to $0.31 per diluted share in the first quarter of 2014. GAAP revenue in the first quarter of 2015 was $526.9 million, as compared to $530.6 million in the first quarter of 2014. GAAP operating income from continuing operations for the first quarter of 2015 was $57.4 million, as compared to $51.8 million in the first quarter of 2014. Adjusted earnings per share was $0.50, as compared to $0.47 in the first quarter of 2014. Adjusted revenue for the quarter was $527.2 million, as compared to $532.1 million in the first quarter of 2014. Adjusted operating income for the first quarter of 2015 was $82.8 million, as compared to $79.4 million for the same period a year ago. For the first quarter of 2015, GAAP operating cash flow from continuing operations, after taking into account approximately $24.0 million of voluntary pension funding, was $37.6 million, as compared to $68.1 million in the comparable period of 2014. Income from continuing operations, before income taxes was $47,960,000 against $40,473,000 a year ago. Capital expenditures was $4,479,000 against $6,020,000 a year ago. For the full year 2015, the company now forecasts GAAP earnings per share from continuing operations in the range of $2.06 to $2.12 and updates on a non-GAAP basis, which is expected to include the adjustments, adjusted earnings per share of $2.54 to $2.60 which now represents 12%-15% constant currency adjusted earnings per share growth as compared to the company's prior guidance of 11%-13%. The guidance now assumes that the stronger U.S. dollar will negatively impact adjusted earnings per share for 2015 by a total of $0.23 as compared to the company’s original guidance of $0.15.

PerkinElmer Seeks Acquisitions

Rob Friel, Chairman and Chief executive Officer PerkinElmer Inc. (NYSE:PKI) said, "I think we look at everything. We look at all opportunities to make PerkinElmer better. I think generally we focused on smaller bolt-on acquisitions because quite frankly I think that the probability of that happening is higher. But quite frankly, we look at small deals, we will look at medium deals, we will look at large deals. I just think as I said, the probability of smaller deals happening are probably higher. Having said that, I think there is -- for a long period of time, there's been a lot of competition in the marketplace. And I think what we've historically said is for us to be able to successfully acquire and integrate deals that makes sense for PerkinElmer and their shareholders is we've got to have good synergies. And those synergies have to either be from a channel perspective of operations or technology."

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PKI:US $53.39 USD 0.00

PKI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Getinge AB kr208.10 SEK +3.70
IDEXX Laboratories Inc $138.72 USD +0.69
MEDNAX Inc $71.37 USD +0.28
QIAGEN NV €22.79 EUR +0.291
Teleflex Inc $129.72 USD +0.81
View Industry Companies
 

Industry Analysis

PKI

Industry Average

Valuation PKI Industry Range
Price/Earnings 36.4x
Price/Sales 2.7x
Price/Book 2.9x
Price/Cash Flow 36.9x
TEV/Sales 2.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PERKINELMER INC, please visit www.perkinelmer.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.